About Lutonix
Lutonix is a company based in Minneapolis (United States) founded in 2007 by Lixiao Wang was acquired by CR Bard in December 2011. Lutonix has raised $35 million across 3 funding rounds from investors including CR Bard, Versant Ventures and Delphi Ventures. Lutonix operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Minneapolis, United States
- Founders Lixiao Wang
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Lutonix Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lutonix
Lutonix has successfully raised a total of $35M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lutonix
Lutonix has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include CR Bard, Versant Ventures and Delphi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked | |
|
VC firm that focuses on early stage investments in the US
|
Locked | Locked | Locked |
Investor details for Lutonix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lutonix
Investment portfolio details for Lutonix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lutonix
Detailed financials for Lutonix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lutonix Comparisons
Peer comparison for Lutonix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lutonix
Lutonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for treating peripheral and coronary vascular disease are developed.
|
|
| Locked | Locked | Locked |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| Locked | Locked | Locked |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| Locked | Locked | Locked |
Smart devices for monitoring coronary artery disease are developed.
|
|
| Locked | Locked | Locked |
Embolization devices are developed using Shape Memory Polymer foams.
|
|
| Locked | Locked | Locked |
Developer a system for venous arterialization of the lower limbs
|
Detailed competitors of Lutonix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lutonix
Complete news archive for Lutonix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lutonix
Lutonix was founded in 2007.
Lutonix is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Lutonix is a funded company, having raised a total of $35M across 3 funding rounds to date.
Lutonix was founded in 2007 in Minneapolis, United States, focusing on the medical device sector. Drug-coated balloon catheters are offered for treating peripheral and coronary artery lesions. Paclitaxel, an anti-proliferative agent, is delivered by the catheters to inhibit restenosis. The company was acquired by Bard in 2011, with operations centered on cardiovascular interventions.
Lutonix's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Lutonix has 5 investors. Key investors include CR Bard, Versant Ventures, Delphi Ventures, USVP, and RiverVest Venture Partners.